19.02.2015 • NewsDede WillamsChris ViehbacherSanofi

Bayer’s Brandicourt Could Be New Sanofi CEO

As the search narrows for a successor to Chris Viehbacher, who was dismissed last year as CEO of French drugmaker Sanofi, French newspaper Le Figaro has identified Bayer HealthCare head Oliver Brandicourt as the most likely candidate.

The name Brandicourt also has been circulating in pharmaceutical industry circles as a possible replacement. Currently, Sanofi is being managed by supervisory board chairman Serge Weinberg.

It was Weinberger who took responsibility for the October 2014 abrupt dismissal of Viehbacher, the company's first non-French CEO, with whom he disagreed on communications strategy.

Brandicourt, a physician who has headed the Bayer business since 2013, previously worked for Pfizer. Prior to that, he was engaged in malaria research, in France and elsewhere.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.